Trovagene, MD Anderson Partner on Transrenal BRAF Mutation Detection
January 03, 2013
Trovagene, MD Anderson Partner on Transrenal BRAF Mutation Detection
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Trovagene Bets on Digital PCR as Detection Technology for Urine-Based MDx Testing Platform
May 3, 2012 / PCR Insider - Trovagene Set to Offer Transrenal KRAS Assay on Bio-Rad dPCR System in January
November 29, 2012 / PCR Insider - Trovagene Using Bio-Rad Digital PCR System for Trans-Renal Pancreatic Cancer MDx
May 31, 2012 / PCR Insider - MDx/CDx Focus: Trovagene, MD Anderson Work to ID KRAS Mutations in Urine; FDA on Device Identifiers
July 3, 2012 / Pharmacogenomics Reporter - As RainDance Readies to Place Digital PCR Systems, Early Users Weigh in on Platform's Potential
January 17, 2013 / PCR Insider